Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000575778 | SCV000673421 | likely benign | Hereditary cancer-predisposing syndrome | 2016-10-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000867885 | SCV001009156 | likely benign | Birt-Hogg-Dube syndrome | 2024-12-30 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003478282 | SCV004219718 | benign | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV005248296 | SCV005896312 | benign | Birt-Hogg-Dube syndrome 1 | 2024-10-22 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |